Trevi Therapeutics (TRVI) Shares Issued (2018 - 2026)

Trevi Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $12.0 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 184.68% year-over-year to $12.0 million in Q1 2026; TTM through Mar 2026 was $12.0 million, a 184.68% increase from a year earlier, with the FY2025 full-year figure at $9.3 million, up 18.58% from the prior year.
• Shares Issued grew to $12.0 million in Q1 2026 per TRVI's latest filing, from $9.3 million in the prior quarter.
• Across five years, Shares Issued topped out at $12.0 million in Q1 2026 and bottomed at $2.0 million in Q2 2022.
• The 5-year median for Shares Issued is $5.1 million (2025), against an average of $5.6 million.
• Across the five-year window, Shares Issued surged 217.43% in 2024 and tumbled 45.93% in 2025, its largest moves.
• Year by year, Shares Issued stood at $4.5 million in 2022, then grew by 19.37% to $5.3 million in 2023, then jumped by 47.66% to $7.8 million in 2024, then grew by 18.58% to $9.3 million in 2025, then advanced by 29.46% to $12.0 million in 2026.
• Per Business Quant, the three latest TRVI Shares Issued figures stand at $12.0 million (Q1 2026), $9.3 million (Q4 2025), and $5.0 million (Q3 2025).